Novo Nordisk Swoops In With $6.5B Bid to Top Pfizer’s M&A Deal With Obesity Biotech Metsera
Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9
Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9
With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs. The post
During Reuters’ Total Health conference in Chicago, four healthcare leaders shared the strategies they believe will help fortify the workforce for the future. The post
[Sponsored] The AI Index in RCM highlights the findings of our survey of 125 medical billing executives who offered insights and feedback on RCM tech.
The cybersecurity process is something you need to invest effort in now. Here’s some insight on conducting a security risk analysis that is impactful for the
Equity has to be built into the deployment strategy from day one, not treated as a future retrofit. That means prioritizing inclusion not only in
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.